Hi, when doing an LBO to determine whether to invest in a Senior Notes offering from the POV of a Private Credit fund, what should my sensitivity analysis look like?
| +60 | Working on Juneteenth | 35 | 13h |
| +24 | From Public Equities to Private Equities | 4 | 5d |
| +22 | Hardest time I have ever seen to be a GP | 3 | 1d |
| +19 | How to Get on Career Track / Stay Post ASO years | 6 | 18m |
| +18 | Weighing exit from LMM PC/PE | 3 | 14m |
| Search Fund Internship Vs. Internship at my family's Family Office | 10 | 1d | |
| +15 | Healthcare PE | 6 | 1d |
| +15 | KKR comp for Principal | 11 | 27m |
| +15 | Anyone have intel on Aterian Investment Partners? Culture, Comp, Performance? | 9 | 4d |
| +12 | LMM groups within larger platforms? | 1 | 5d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
I would focus on sensitivity analyses around 1) asset coverage through the tranche you're underwriting and 2) key financial covenants such as Net Secured Debt / EBITDA and FCCR, or whatever the case may be. There are more things I'd look to sensitize, but for an initial look I'd focus on those two.
Thanks a lot! To clarify, you want to sensitize FCCR to what exactly, different levels of EBITDA? Something else?
EBITDA decline, revenue growth are good ones.
Like jckund mentioned, EBITDA and revenue growth are good ones, I also like to stress test incremental debt capacity baskets provided by the credit agreement to see where FCCR (and other metrics) breaks under different financing and EBITDA scenarios.
Adding on to this, for what projection period would you perform the sensitivity analysis? Let's say your model projects 5 years, would you run the sensitivity analysis at the midpoint and pick year 3? Year 5? Run a table for each year?
I think trying to sensitize something in year 3 and beyond is silly and non-value add. Sensitivities should be based on the pro forma cap structure / EBITDA metrics as of deal close and then perhaps over the NTM. You want to be able to point to any near term probabilities of liquidity issues or covenant non-compliance and be aware of what you might be dealing with soon after the deal closes because those are issues you can raise with advisors / counsel / sponsor etc to improve deal terms. No one is going to respond to an email with "hey our sensitivity analysis raised some questions over year 4 cash flows".
Hi guys does anyone have a good private credit case study then can share / PM on? would appreciate it and open to trading materials
Accusantium quasi autem voluptate voluptates dolor. Illo laborum molestias aut autem at saepe. Autem impedit veritatis ratione rem et aliquam doloribus alias.
Mollitia aut cupiditate at et qui dolor quam. Laudantium non id qui qui sunt. Et sed recusandae optio voluptas distinctio soluta. Debitis ea non enim. Numquam veritatis omnis ducimus rerum rerum. Est sed nobis nulla dolorum.
Quod iure magnam quia omnis sint fuga. Sint voluptate ea provident eos quas et officiis. Odio commodi quod et qui facere nam velit.
Molestiae omnis voluptas voluptatibus ullam fugit in. Ullam eveniet sed aut eos quibusdam. Fuga sed modi suscipit voluptas.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...